| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/11/2010 | US20100035827 Multivalent metal salts of boronic acids |
| 02/11/2010 | US20100035797 Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 02/11/2010 | US20100034823 Crystalline anti-hTNFalpha antibodies |
| 02/11/2010 | US20100034746 Animal model, system, and method for screening compounds for antithrombotic and/or thrombolytic activity |
| 02/11/2010 | US20100032374 Phosphate binding materials and their uses |
| 02/11/2010 | CA2733497A1 Anti-hepcidin-25 selective antibodies and uses thereof |
| 02/11/2010 | CA2733200A1 Conjugated proteins with prolonged in vivo efficacy |
| 02/11/2010 | CA2733075A1 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
| 02/11/2010 | CA2732791A1 Methods of treating thalassemia |
| 02/10/2010 | EP2151247A1 Solid dialysis preparation |
| 02/10/2010 | EP2150561A1 Demannosylated recombinant factor vii for the treatment of patients with haemophilia a |
| 02/10/2010 | EP2150251A1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity |
| 02/10/2010 | EP2150248A2 Glutamate receptor antagonists and methods of use |
| 02/10/2010 | EP1817287B1 Aromatic ether derivatives useful as thrombin inhibitors |
| 02/10/2010 | EP1490365B1 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 02/10/2010 | EP1411932B1 Substituted oxazolidinones for combinational therapy |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659293 α-Amino-N-hydroxy-acetamide derivatives |
| 02/09/2010 | US7658952 Dialysis solutions containing pyrophosphates |
| 02/09/2010 | CA2625906C Lazaroids-based compositions and methods for preventing adhesion formation using the same |
| 02/09/2010 | CA2466372C Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 02/09/2010 | CA2431079C Method and composition for the treatment of diabetic neuropathy |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2311670C Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 02/09/2010 | CA2287469C Interactive system for presenting and eliminating substances |
| 02/04/2010 | WO2010014199A2 Uses of morelloflavone |
| 02/04/2010 | WO2010012438A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/04/2010 | WO2009150257A3 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 02/04/2010 | US20100029766 Blends Comprising a Substituted Fatty Acid or a Derivative Thereof |
| 02/04/2010 | US20100029727 1, 3, 4 -oxadiazole derivatives as dgat1 inhibitors |
| 02/04/2010 | US20100029724 Screening method |
| 02/04/2010 | US20100029688 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 02/04/2010 | US20100029651 Aryl-substituted heterocycles, and use thereof |
| 02/04/2010 | US20100029645 Inhibitors of Cytosolic Phospholipase A2 |
| 02/04/2010 | US20100029641 Aryl sulfamide derivatives and methods of their use |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029582 Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label |
| 02/04/2010 | US20100029555 G-csf site-specific mono-conjugates |
| 02/04/2010 | US20100028402 Nanoparticle-based anticoagulant |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028331 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 02/04/2010 | US20100028319 Composition for prevention or treatment of diabetes |
| 02/04/2010 | CA2730659A1 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 02/03/2010 | EP2149578A1 Novel crystalline polymorphs of clopidogrel |
| 02/03/2010 | EP2149563A1 Novel pyrimidine compound having dibenzylamine structure, and medicine comprising the compound |
| 02/03/2010 | EP2148871A1 Quinoline-carboxamide derivatives as p2y12 antagonists |
| 02/03/2010 | EP2148681A2 Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding |
| 02/03/2010 | EP1778677B1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 02/03/2010 | EP1078636B1 Pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 02/03/2010 | CN100586444C Method of processing ginseng for medicinal use and composition |
| 02/02/2010 | US7655674 Hedgehog antagonists that inhibit the hedgehog pathway in a smoothened gain-of-function cell with an IC50 within a factor of 20, 10, or even a factor of 5, of the IC50 with which they inhibit the hedgehog pathway in a patched-null cell |
| 02/02/2010 | US7655637 N-pyrazole A2A receptor agonists |
| 02/02/2010 | US7655633 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2390858C N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2383412C Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 02/02/2010 | CA2358581C Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 02/02/2010 | CA2316172C Indole derivatives as inhibitors of factor xa |
| 02/02/2010 | CA2282842C A method of recovering highly purified vwf or factor viii/vwf-complex |
| 01/28/2010 | WO2010010909A1 Therapeutic agent for chronic renal failure |
| 01/28/2010 | WO2010009775A1 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 01/28/2010 | US20100022748 Prophylactic agent for renal failure |
| 01/28/2010 | US20100022652 Antimicrobial and Anticoagulant Compositions and Methods |
| 01/28/2010 | US20100022630 Method of treatment using fatty acid synthesis inhibitors |
| 01/28/2010 | US20100022619 Compositions and their uses directed to ptpr alpha |
| 01/28/2010 | US20100022603 Peroxisome proliferator-activated receptor agonists; insulin resistance; metabolic diseases; diabetes; dyslipidemia; 2-Ethoxy-N-[5-(5-isopropyl-[1,3,4]thiadiazol-2-ylsulfamoyl)-indan-2-yl]-4-trifluoromethyl-benzamide |
| 01/28/2010 | US20100022542 Compounds exhibiting thrombopoietin receptor agonism |
| 01/28/2010 | US20100022536 Inhibitors of Cytosolic Phospholipase A2 |
| 01/28/2010 | US20100022528 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 01/28/2010 | US20100022519 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 01/28/2010 | US20100022507 Aminopyrimidines useful as inhibitors of protein kinases |
| 01/28/2010 | US20100022477 Fused aromatic ptp-1b inhibitors |
| 01/28/2010 | US20100022452 Nanobodies for the treatment of aggregation-mediated disorders |
| 01/28/2010 | US20100022445 Biologically active peptides |
| 01/28/2010 | US20100022442 Compositions and methods for increasing serum antioxidant concentrations, decreasing serum triglyceride levels, inhibiting insulin-receptor signaling activity, increasing serum ghrelin levels, and decreasing serum tnf-alpha levels |
| 01/28/2010 | US20100021575 Hypolipidemic composition and its use |
| 01/28/2010 | US20100021572 Nutritional Drink |
| 01/28/2010 | US20100021569 Use of Extracts from AMTHS plants in Lowering Blood Glucose |
| 01/28/2010 | US20100021568 Anti-Obesity Product And Its Method Of Preparation |
| 01/28/2010 | US20100021538 Pharmaceutical compositions containing heparin derivatives |
| 01/28/2010 | US20100021528 Conformable structured therapeutic dressing |
| 01/28/2010 | US20100021517 Non-woven fiber fabric |
| 01/28/2010 | US20100021506 Nitric oxide gel apparatus and method |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021433 Disease treatment via developing non-syngeneic graft transplantation |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | DE202009015258U1 Mittel und hygienisches Erzeugnis zur Vorbeugung von Hämorrhoiden und Beseitigung von Hautreizung Central and hygienic product for the prevention of hemorrhoids and eliminate skin irritation |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP2147096A2 Modified factor vii polypetides and uses thereof |
| 01/27/2010 | EP2146733A2 Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
| 01/27/2010 | CN101632669A Method of using diketopiperazines and composition containing them |
| 01/27/2010 | CN100584954C Method for producing paeonin metabolite-I by short lactobacillin fermentation |